Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands.

Romy van der GroefPascal H P de JongDirk Jan HijnenChristien J van der WoudeJan A M van LaarPaul-Hugo M van der KuyJan-Dietert BrugmaAnnelieke Pasma

Published in: Patient preference and adherence (2023)

This study showed that the first SARS-CoV-2 lockdown negatively impacts adherence to biological treatment in IMID patients. Therefore, treating physicians should be aware of this problem to minimize the potential harmful effects of non-adherence.

Keyphrases

sars cov
end stage renal disease
primary care
ejection fraction
newly diagnosed
oxidative stress
type diabetes
metabolic syndrome
glycemic control
risk assessment
climate change
human health
coronavirus disease
smoking cessation